A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks
Clinical trial NCT07752407 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07752407
- Sponsor
- Phathom Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-25
- Primary completion
- 2027-10-20
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.